Biomotion Sciences Warran...
0.03
-0.01 (-32.58%)
At close: Jan 02, 2025, 9:00 PM
0.03
-0.40%
After-hours Jan 14, 2025, 05:04 PM EST
undefined%
Bid 0.03
Market Cap 3.37M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) n/a
PE Ratio (ttm) n/a
Forward PE n/a
Analyst n/a
Ask 0.05
Volume 5
Avg. Volume (20D) 0
Open 0.03
Previous Close 0.04
Day's Range 0.03 - 0.03
52-Week Range 0.03 - 0.03
Beta undefined

About SLXNW

Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, ...

Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees NaN
Stock Exchange NASDAQ
Ticker Symbol SLXNW
No News article available yet